• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肌肉浸润性膀胱癌的分子全景。

Molecular Landscape of Non-Muscle Invasive Bladder Cancer.

机构信息

Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA.

Scott Department of Urology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

Cancer Cell. 2017 Nov 13;32(5):550-551. doi: 10.1016/j.ccell.2017.08.015.

DOI:10.1016/j.ccell.2017.08.015
PMID:29136502
Abstract

In this issue of Cancer Cell, Hurst et al. report an integrated analysis of non-invasive (stage Ta) bladder cancer. Two genomic subtypes are distinguished by chromosome 9q loss, resulting in increased AKT/PI3K/mTOR signaling. Tumors from female patients have a higher frequency of KDM6A mutations.

摘要

在本期《癌细胞》中,赫斯特等人报告了一项非侵入性(Ta 期)膀胱癌的综合分析。两种基因组亚型通过染色体 9q 缺失来区分,导致 AKT/PI3K/mTOR 信号的增加。女性患者的肿瘤具有更高频率的 KDM6A 突变。

相似文献

1
Molecular Landscape of Non-Muscle Invasive Bladder Cancer.非肌肉浸润性膀胱癌的分子全景。
Cancer Cell. 2017 Nov 13;32(5):550-551. doi: 10.1016/j.ccell.2017.08.015.
2
Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.具有不同代谢特征及KDM6A突变频率存在女性性别偏向的非侵袭性膀胱癌的基因组亚型
Cancer Cell. 2017 Nov 13;32(5):701-715.e7. doi: 10.1016/j.ccell.2017.08.005.
3
Bladder cancer: Genomics of noninvasive disease.膀胱癌:非侵袭性疾病的基因组学
Nat Rev Urol. 2018 Jan;15(1):1. doi: 10.1038/nrurol.2017.207. Epub 2017 Dec 5.
4
The evolution of bladder cancer genomics: What have we learned and how can we use it?膀胱癌基因组学的演变:我们学到了什么以及如何应用它?
Urol Oncol. 2018 Jul;36(7):313-320. doi: 10.1016/j.urolonc.2018.02.017. Epub 2018 Mar 21.
5
Differential Occupancy and Regulatory Interactions of KDM6A in Bladder Cell Lines.KDM6A 在膀胱细胞系中的差异占据和调控相互作用。
Cells. 2023 Mar 8;12(6):836. doi: 10.3390/cells12060836.
6
Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.与膀胱癌中近端9号染色体p臂至q臂以及远端9号染色体q臂相关的两个肿瘤抑制基因座的证据及GAS1和PTC突变的初步筛查。
Cancer Res. 1996 Nov 1;56(21):5039-43.
7
Implication of in bladder cancer.在膀胱癌中的意义。
Pharmacogenomics. 2023 Jun;24(9):509-522. doi: 10.2217/pgs-2023-0027. Epub 2023 Jul 17.
8
Different expression patterns of histone H3K27 demethylases in renal cell carcinoma and bladder cancer.组蛋白H3K27去甲基化酶在肾细胞癌和膀胱癌中的不同表达模式。
Cancer Biomark. 2017;18(2):125-131. doi: 10.3233/CBM-160003.
9
Molecular alterations associated with bladder cancer initiation and progression.与膀胱癌起始和进展相关的分子改变。
Scand J Urol Nephrol Suppl. 2008 Sep(218):154-65. doi: 10.1080/03008880802291915.
10
Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer.人类膀胱癌中9号染色体长臂杂合性缺失及p53改变
Cancer. 2005 Nov 1;104(9):1918-23. doi: 10.1002/cncr.21423.

引用本文的文献

1
Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discovery.膀胱癌异种移植瘤的分子谱分析确定了相关分子亚型,并为生物标志物发现提供了资源。
Transl Oncol. 2025 Feb;52:102269. doi: 10.1016/j.tranon.2024.102269. Epub 2025 Jan 13.
2
Prognostic value and immune landscapes of disulfidptosis‑related lncRNAs in bladder cancer.二硫键连接的细胞焦亡相关长链非编码RNA在膀胱癌中的预后价值及免疫图谱
Mol Clin Oncol. 2024 Dec 13;22(2):19. doi: 10.3892/mco.2024.2814. eCollection 2025 Feb.
3
Actin-related protein 2/3 complex subunit 1B promotes ovarian cancer progression by regulating the AKT/PI3K/mTOR signaling pathway.
肌动蛋白相关蛋白2/3复合体亚基1B通过调节AKT/PI3K/mTOR信号通路促进卵巢癌进展。
J Transl Int Med. 2024 Oct 1;12(4):406-423. doi: 10.2478/jtim-2024-0025. eCollection 2024 Sep.
4
Somatic Mutation of the Non-Muscle-Invasive Bladder Cancer Associated with Early Recurrence.与早期复发相关的非肌层浸润性膀胱癌的体细胞突变
Diagnostics (Basel). 2023 Oct 13;13(20):3201. doi: 10.3390/diagnostics13203201.
5
Kavalactone Kawain Impedes Urothelial Tumorigenesis in UPII-Mutant Ha-Ras Mice via Inhibition of mTOR Signaling and Alteration of Cancer Metabolism.卡瓦内酯卡瓦因通过抑制 mTOR 信号和改变癌症代谢来阻碍 UPII 突变 Ha-Ras 小鼠的尿路上皮肿瘤发生。
Molecules. 2023 Feb 9;28(4):1666. doi: 10.3390/molecules28041666.
6
Epigenetic regulation of core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcome.核心启动子的表观遗传调控在膀胱癌进展和治疗结果中控制miR-143/145簇。
Mol Ther Nucleic Acids. 2022 Oct 7;30:311-322. doi: 10.1016/j.omtn.2022.10.001. eCollection 2022 Dec 13.
7
Immune status for monitoring and treatment of bladder cancer.膀胱癌监测和治疗的免疫状况。
Front Immunol. 2022 Sep 8;13:963877. doi: 10.3389/fimmu.2022.963877. eCollection 2022.
8
Narrative review: update on immunotherapy and pathological features in patients with bladder cancer.叙述性综述:膀胱癌患者免疫治疗及病理特征的最新进展
Transl Androl Urol. 2021 Mar;10(3):1521-1529. doi: 10.21037/tau-20-1436.
9
tRNA-Derived Fragments (tRFs) in Bladder Cancer: Increased 5'-tRF-LysCTT Results in Disease Early Progression and Patients' Poor Treatment Outcome.膀胱癌中的tRNA衍生片段(tRFs):5'-tRF-LysCTT增加导致疾病早期进展和患者治疗效果不佳。
Cancers (Basel). 2020 Dec 6;12(12):3661. doi: 10.3390/cancers12123661.
10
Immunotherapy in non-muscle-invasive bladder cancer: current status and future directions.非肌肉浸润性膀胱癌的免疫治疗:现状与未来方向。
World J Urol. 2021 May;39(5):1319-1329. doi: 10.1007/s00345-020-03474-8. Epub 2020 Oct 15.